Provided by Tiger Fintech (Singapore) Pte. Ltd.

Actinium Pharmaceuticals

1.42
-0.2000-12.35%
Post-market: 1.440.0200+1.41%19:59 EDT
Volume:4.28M
Turnover:6.12M
Market Cap:44.30M
PE:-0.96
High:1.63
Open:1.61
Low:1.42
Close:1.62
Loading ...
Feb 21, 2023

Major Issues Report

8-K - Current report
Feb 06, 2023

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Dec 30, 2022

Major Issues Report

8-K - Current report
Dec 09, 2022

Major Issues Report

8-K - Current report
Nov 14, 2022

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Oct 31, 2022

Major Issues Report

8-K - Current report
Aug 19, 2022

Employee Stock Ownership

S-8 - Securities to be offered to employees in employee benefit plans
Aug 12, 2022

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Jun 29, 2022

Major Issues Report

8-K - Current report
May 13, 2022

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Apr 13, 2022

Major Issues Report

8-K - Current report
Mar 25, 2022

Annual Report

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Feb 09, 2022

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Sep 03, 2021

Statement Of Changes In Beneficial Ownership

4 - Statement of changes in beneficial ownership of securities
Sep 03, 2021

Statement Of Changes In Beneficial Ownership

4 - Statement of changes in beneficial ownership of securities
Sep 03, 2021

Statement Of Changes In Beneficial Ownership

4 - Statement of changes in beneficial ownership of securities
Sep 03, 2021

Statement Of Changes In Beneficial Ownership

4 - Statement of changes in beneficial ownership of securities
Sep 03, 2021

Statement Of Changes In Beneficial Ownership

4 - Statement of changes in beneficial ownership of securities
Jul 30, 2021

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
May 14, 2021

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]